Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Prescribing & titration is anticipated to lead with 46.0% share in 2026
Exon skipping of the NF1 mutant in BC patient 1-derived primary cells as a potential therapy To improve drug responsiveness in patients with BC harboring NF1 mutations, we assessed exon-skipping therapy as an advanced personalized therapeutic strategy
(Recommended charge rate: 0.5C1C) Do not fully discharge the battery during use
During your appointment, Dr Berkowitz will also be able to offer an estimation of what results you can expect and the possible duration of your Skin Brightening programme
US$ 21.58
US$ 27.05
US$ 27.01
US$ 26.69
US$ 27.74
